Search results
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WKMG ClickOrlando· 9 hours agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 4 hours agoHEALTH NEWS The Federal Trade Commission is challenging hundreds of pharmaceutical patent listings...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 8 hours agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
USPTO Issues Guidance on Use of AI-Based Tools
The National Law Review· 4 hours agoOn April 11, 2024, the U.S. Patent and Trademark Office (USPTO) issued Guidance on Use of Artificial-Intelligence-Based Tools (Guidance), which applies...
Ozempic and 19 other drugs have 'junk' patents, the FTC says in a new challenge
Quartz· 6 hours agoThe U.S. Federal Trade Commission (FDA) announced on Tuesday that it is disputing over 300 patent...
